FOLH1 and nonpapillary renal cell carcinoma: These results suggest that PSMA-radioligands uptake might be a valuable prognostic factor in ccRCC patients; in this context, more prospective studies are needed to assess its potential in this setting in combination with other prognostic factors as well as an independent variable.